跳至主要内容
临床试验/ACTRN12611000130965
ACTRN12611000130965已完成未知

Randomized placebo-controlled clinical trial assessing the effect of two probiotic supplements on upper respiratory tract and gastrointestinal illness during a winter period in healthy physically active adult subjects.

Danisco Finland0 个研究点目标入组 450 人开始时间: 2011年2月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
450

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion to the study will be determined according to physical activity levels with subjects required to be undertaking 3 exercise sessions weekly and a questionnaire to determine subject’s health in the previous month

排除标准

  • All participants will be required to declare their use of dietary and/or ergogenic aids that may influence underlying immune function and/or exercise performance. All participants on immuno-modulatory medications will be excluded, including those on steroid based anti-asthma treatments. Subjects who have been on antibiotic treatments in the previous month will also be excluded. A daily illness log will be used to monitor training, health status, diet, use of supplements and other therapeutic agents. Subjects with any symptoms of gastrointestinal disease, such as Crohn’s disease, coelic disease and so on will also be excluded.

研究者

相似试验